Harvard Bioscience Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 01/29/2026 | 3.20 M | $2.14 M | 100.00% | 7.18% | |
| VANGUARD GROUP INC | 01/29/2026 | 1.92 M | $1.29 M | 3.86% | 4.32% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 1.77 M | $1.18 M | 65.71% | 3.98% |
| MEROS INVESTMENT MANAGEMENT, LP | 02/17/2026 | 1.22 M | $814.37 K | 32.60% | 2.73% |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 1.11 M | $741.49 K | 1,008.69% | 2.49% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 1.02 M | $683.01 K | 17.59% | 2.29% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 1.01 M | $677.10 K | 113.52% | 2.27% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 878.56 K | $587.58 K | 261.31% | 1.97% |
| BLACKROCK, INC. | 02/12/2026 | 622.30 K | $416.19 K | 0.15% | 1.40% |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 02/06/2026 | 600.00 K | $401.28 K | 100.00% | 1.35% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 546.07 K | $365.21 K | -4.48% | 1.23% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 460.79 K | $308.25 K | 4.28% | 1.03% |
| JANE STREET GROUP, LLC | 02/12/2026 | 415.16 K | $277.66 K | 923.47% | 0.93% |
| PORTOLAN CAPITAL MANAGEMENT, LLC | 02/17/2026 | 409.65 K | $273.97 K | 100.00% | 0.92% |
| WILLIAMS & NOVAK, LLC | 02/05/2026 | 348.80 K | $233.28 K | 26.61% | 0.78% |
| CITIGROUP INC | 02/13/2026 | 193.83 K | $129.63 K | 12,744.80% | 0.44% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 02/13/2026 | 184.68 K | $123.51 K | 100.00% | 0.41% |
| RBF CAPITAL, LLC | 02/17/2026 | 160.00 K | $107.01 K | 0.00% | 0.36% |
| STATE STREET CORP | 02/13/2026 | 149.35 K | $99.89 K | 0.00% | 0.34% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 139.87 K | $93.54 K | 65.82% | 0.31% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/09/2026 | 139.22 K | $93.11 K | 0.00% | 0.31% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 126.22 K | $84.42 K | 0.00% | 0.28% |
| NORTHERN TRUST CORP | 02/17/2026 | 91.97 K | $61.51 K | -36.65% | 0.21% |
| VIRTU FINANCIAL LLC | 02/23/2026 | 59.51 K | $40.00 K | 100.00% | 0.13% |
| GAMCO INVESTORS, INC. ET AL | 02/05/2026 | 57.00 K | $38.12 K | 100.00% | 0.13% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 49.75 K | $33.27 K | 291.93% | 0.11% |
| PASADENA PRIVATE WEALTH, LLC | 02/10/2026 | 45.00 K | $30.10 K | -81.55% | 0.10% |
| LEGATO CAPITAL MANAGEMENT LLC | 02/06/2026 | 43.47 K | $29.07 K | 210.37% | 0.10% |
| CITADEL ADVISORS LLC | 02/17/2026 | 42.99 K | $28.75 K | 100.00% | 0.10% |
| XTX TOPCO LTD | 02/17/2026 | 39.35 K | $26.32 K | 100.00% | 0.09% |
| GABELLI FUNDS LLC | 02/05/2026 | 39.00 K | $26.08 K | 0.00% | 0.09% |
| FMR LLC | 02/17/2026 | 32.90 K | $22.00 K | -27.84% | 0.07% |
| JANE STREET GROUP, LLC | 02/12/2026 | 29.80 K | $19.93 K | 100.00% | 0.07% |
| CALLAN FAMILY OFFICE, LLC | 02/12/2026 | 29.79 K | $19.92 K | -0.18% | 0.07% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 27.79 K | $18.59 K | -94.40% | 0.06% |
| GREENWOOD CAPITAL ASSOCIATES LLC | 01/26/2026 | 27.75 K | $18.56 K | 0.00% | 0.06% |
| GROUP ONE TRADING, L.P. | 02/12/2026 | 25.51 K | $17.06 K | 1,307.23% | 0.06% |
| ABEL HALL, LLC | 02/17/2026 | 25.28 K | $16.91 K | -21.50% | 0.06% |
| UBS GROUP AG | 01/29/2026 | 21.21 K | $14.19 K | 59.75% | 0.05% |
| CITADEL ADVISORS LLC | 02/17/2026 | 19.30 K | $12.91 K | -54.48% | 0.04% |
| TWO SIGMA SECURITIES, LLC | 02/17/2026 | 17.55 K | $11.74 K | 100.00% | 0.04% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 17.03 K | $11.39 K | -54.29% | 0.04% |
| MORGAN STANLEY | 02/13/2026 | 16.69 K | $11.16 K | -0.10% | 0.04% |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 02/13/2026 | 16.54 K | $11.06 K | 100.00% | 0.04% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 14.72 K | $9.84 K | 100.00% | 0.03% |
| SIMPLEX TRADING, LLC | 02/11/2026 | 13.79 K | $9.23 K | 401.64% | 0.03% |
| CERTUITY, LLC | 01/30/2026 | 13.68 K | $9.15 K | 0.00% | 0.03% |
| GSK PLC | 02/12/2026 | 11.15 K | $7.46 K | 100.00% | 0.03% |
| ETHIC INC. | 02/03/2026 | 10.94 K | $7.32 K | -12.03% | 0.02% |
| BALBOA WEALTH PARTNERS | 01/16/2026 | 10.00 K | $6.69 K | -14.89% | 0.02% |
Harvard Bioscience Inc. institutional Ownership - FAQ's
During the previous two years, 97 institutional investors and hedge funds held shares of Harvard Bioscience Inc.. The most heavily invested institutionals were:
ESSEX INVESTMENT MANAGEMENT CO LLC: 0
BNP PARIBAS ARBITRAGE, SNC: 0
DIMENSIONAL FUND ADVISORS LP: 0
SBI Securities Co., Ltd.: 0
Ethic Inc.: 0
Pasadena Private Wealth, LLC: 0
39.18% of Harvard Bioscience Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 24.51 M shares in the last 24 months. This purchase volume represents approximately $12.01 M in transactions.